Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
750.50    5.00 (0.67%)
Bid:
750.00
Ask:
751.00
Spread: 1.00 (0.133%)
Market Cap: £2.52b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Infrastructure debt facility

14 Sep 2020 14:04

RNS Number : 9331Y
Drax Group PLC
14 September 2020
 

14 September 2020

Drax Group plc

("Drax", the "Group" or the "Company"; Symbol: DRX)

 

Infrastructure debt facility - extended maturity profile, reduced cost of debt

 

Drax is pleased to announce that it has agreed a new infrastructure term loan facilities agreement (the "Agreement") that provides committed facilities of approximately £160 million with a range of maturities between 2024 and 2030(1), further extending Drax's debt maturity profile.

 

The facilities have an average margin of 2.07%(2). Taken together with Drax's existing borrowing, including a carbon-linked ESG(3) facility which was recently extended to 2025, this Agreement further reduces the Group's all-in cost of debt below 4%.

 

The Agreement also includes an option for Drax to obtain up to a further £75 million of facilities, if agreed between Drax and its lenders. If utilised, these additional facilities could have a maturity of up to 2030.

 

The facilities under this Agreement also have a delayed draw(4) and proceeds are expected to be used in the ordinary course of business.

 

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Selina Williams

+44 (0) 7912 230 393

 

Website: www.drax.com

 

END

 

Note

(1) €25 million in 2024, €70 million in 2026, £45 million in 2027 and €31.5 million in 2030.

Euro facilities have been converted to £GBP for the purposes of this announcement only at a rate of €1.10/GBP£1. Drax intends that foreign exchange hedging of any Euro funds into £GBP will take place in advance of drawing funds.

(2) Linked to LIBOR and EURIBOR. The weighted average margin of the facilities including the annual amortised cost in relation to duration fees.

(3) The Environmental, Social and Governance (ESG) facility includes a mechanism that adjusts the rate of interest paid based on Drax's carbon emissions against an annual benchmark, reflecting Drax's continued commitment to reducing its carbon emissions as a part of its overall purpose of enabling a zero-carbon, lower cost energy future and an ambition to become carbon negative by 2030

(4) Six months, with the exception of the €31.5 million facility due in 2030 which can be drawn up to 13 November 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKKQBKNBKDDCD
Date   Source Headline
26th Nov 20245:42 pmRNSTransaction in Own Shares
25th Nov 20246:01 pmRNSTransaction in Own Shares
22nd Nov 20245:51 pmRNSTransaction in Own Shares
21st Nov 20246:23 pmRNSTransaction in Own Shares
20th Nov 20246:10 pmRNSTransaction in Own Shares
19th Nov 20245:51 pmRNSTransaction in Own Shares
18th Nov 20245:55 pmRNSTransaction in Own Shares
15th Nov 20245:45 pmRNSTransaction in Own Shares
14th Nov 20245:39 pmRNSTransaction in Own Shares
13th Nov 20246:20 pmRNSTransaction in Own Shares
12th Nov 20246:16 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTrading Update
11th Nov 20245:39 pmRNSTransaction in Own Shares
8th Nov 20246:23 pmRNSTransaction in Own Shares
6th Nov 20245:53 pmRNSTransaction in Own Shares
5th Nov 20245:56 pmRNSTransaction in Own Shares
4th Nov 20245:42 pmRNSTransaction in Own Shares
4th Nov 202411:49 amRNSTotal Voting Rights
1st Nov 20245:34 pmRNSTransaction in Own Shares
31st Oct 20245:37 pmRNSTransaction in Own Shares
30th Oct 20245:31 pmRNSTransaction in Own Shares
29th Oct 20245:50 pmRNSTransaction in Own Shares
28th Oct 20245:28 pmRNSTransaction in Own Shares
25th Oct 20245:22 pmRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20246:27 pmRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSShare Buyback Programme
21st Oct 20245:50 pmRNSTransaction in Own Shares
21st Oct 20243:30 pmRNSDirector/PDMR Shareholding
18th Oct 20245:54 pmRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20246:20 pmRNSTransaction in Own Shares
10th Oct 20245:34 pmRNSTransaction in Own Shares
9th Oct 20245:43 pmRNSTransaction in Own Shares
8th Oct 20245:46 pmRNSTransaction in Own Shares
7th Oct 20245:43 pmRNSTransaction in Own Shares
7th Oct 20248:45 amRNSAdditional Listing
7th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20245:35 pmRNSTransaction in Own Shares
2nd Oct 20245:47 pmRNSTransaction in Own Shares
1st Oct 20246:12 pmRNSTransaction in Own Shares
1st Oct 202412:49 pmRNSNotice of Change to Director Details
1st Oct 20249:47 amRNSBlock listing Interim Review
1st Oct 20249:45 amRNSBlock listing Interim Review
1st Oct 20249:43 amRNSBlock listing Interim Review
1st Oct 20249:42 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.